A detailed history of Nisa Investment Advisors, LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 206 shares of HRTX stock, worth $319. This represents 0.0% of its overall portfolio holdings.

Number of Shares
206
Previous 299 31.1%
Holding current value
$319
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$1.73 - $3.67 $160 - $341
-93 Reduced 31.1%
206 $0
Q2 2024

Jul 19, 2024

BUY
$2.32 - $3.86 $313 - $521
135 Added 82.32%
299 $1,000
Q1 2024

May 01, 2024

BUY
$1.71 - $3.06 $109 - $195
64 Added 64.0%
164 $0
Q4 2023

Jan 25, 2024

SELL
$0.54 - $1.82 $531 - $1,792
-985 Reduced 90.78%
100 $0
Q2 2023

Aug 11, 2023

SELL
$1.11 - $2.88 $111 - $288
-100 Reduced 8.44%
1,085 $1,000
Q1 2023

May 02, 2023

BUY
$1.51 - $3.25 $49 - $107
33 Added 2.86%
1,185 $2,000
Q4 2022

Feb 02, 2023

BUY
$2.25 - $4.67 $150 - $312
67 Added 6.18%
1,152 $3,000
Q2 2022

Aug 03, 2022

SELL
$2.3 - $6.29 $129,259 - $353,498
-56,200 Reduced 98.11%
1,085 $3,000
Q1 2022

Apr 29, 2022

BUY
$4.63 - $9.94 $260,206 - $558,628
56,200 Added 5179.72%
57,285 $328,000
Q4 2021

Feb 03, 2022

SELL
$8.35 - $12.6 $72,678 - $109,670
-8,704 Reduced 88.92%
1,085 $9,000
Q3 2021

Oct 18, 2021

BUY
$10.13 - $15.0 $46,638 - $69,060
4,604 Added 88.79%
9,789 $105,000
Q4 2020

Jan 25, 2021

BUY
$14.61 - $22.14 $13,879 - $21,033
950 Added 22.43%
5,185 $110,000
Q3 2020

Oct 20, 2020

BUY
$13.67 - $17.77 $46,478 - $60,418
3,400 Added 407.19%
4,235 $63,000
Q2 2020

Jul 27, 2020

BUY
$10.89 - $21.47 $1,034 - $2,039
95 Added 12.84%
835 $12,000
Q1 2020

Apr 17, 2020

BUY
$10.23 - $24.56 $2,762 - $6,631
270 Added 57.45%
740 $9,000
Q3 2019

Oct 17, 2019

BUY
$16.36 - $21.39 $2,617 - $3,422
160 Added 51.61%
470 $9,000
Q3 2018

Oct 16, 2018

BUY
$30.0 - $40.85 $9,300 - $12,663
310 New
310 $10,000

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $184M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.